Ivan Liachko

Ivan Liachko is the founder and CEO of Phase Genomics, a company dedicated to maximizing the impact of genomics on society. With most biological information still unexplored, Phase empowers researchers to make breakthrough discoveries using advanced molecular and computational tools—from tracking viruses to detecting chromosomal abnormalities in cancer. By developing new genomic methods, the company drives innovation across research, industry, and the clinic.

A molecular geneticist with over 20 years of experience in wet-lab and computational biology, Ivan is passionate about using genomics to improve the world and mentoring scientists interested in commercialization. He earned his Ph.D. from Cornell, has authored 50+ peer-reviewed papers, and holds multiple patents in microbial genomics and synthetic biology. As one of the original inventors of Phase’s core technology, he has served as CEO since its founding.